Advanced Deferred Long Term Liab from 2010 to 2024
| AMS Stock | 212.50 5.50 2.66% |
Deferred Long Term Liabilities | First Reported 2016-09-30 | Previous Quarter 12.6 M | Current Value 12.6 M | Quarterly Volatility 3.6 M |
Check Advanced Medical financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Advanced Medical's main balance sheet or income statement drivers, such as Depreciation And Amortization of 11.3 M, Interest Expense of 250.6 K or Total Revenue of 132.5 M, as well as many indicators such as . Advanced financial statements analysis is a perfect complement when working with Advanced Medical Valuation or Volatility modules.
Advanced | Deferred Long Term Liab |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Other Information on Investing in Advanced Stock
Advanced Medical financial ratios help investors to determine whether Advanced Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Advanced with respect to the benefits of owning Advanced Medical security.